These data were consistent with the aforementioned results indicating that F13B, FGA, FGB, FGG, C1QB, C1QC, C4BPA, and C4BPB were upregulated in plasma sEVs from patients with HCC. This evidence concerns the gene FGB and hepatocellular carcinoma.